Literature DB >> 3213975

Effects of long-term testosterone exposure on ovarian function and morphology in the rhesus monkey.

C Faiman1, F I Reyes, D W Dent, G B Fuller, W C Hobson, J A Thliveris.   

Abstract

This study was aimed at developing a model in the rhesus monkey for the human gynecologic disorder termed the polycystic ovary syndrome (PCOS). The effects of chronic constant androgen exposure upon quantitative ovarian morphology and ovulatory function were examined. Twenty-five normally cycling females, aged 4-12 yr and weighing 3.3-8.2 kg, were enrolled in the study in random fashion. Seventeen animals were implanted subcutaneously (s.c.) with 10 or 25 mg testosterone-filled silastic tubing so as to maintain steady serum levels of testosterone averaging 80 ng/dl (low-dose group, n = 8) and 115 ng/dl (high-dose group, n = 9) for 13-16 months. Eight animals served as controls (sham implants); in these, mean serum testosterone levels averaged 24 ng/dl. No effect of androgen treatment was observed on ovulatory function as gauged by periodic luteal phase progesterone determinations and the presence of a fresh corpus luteum at laparoscopy. Menstrual cycle frequency (number of cycles over number of months of observation) was, however, slightly but significantly (P less than 0.05) reduced in the high-dose (88.9%) vs. the control (96.7%) and low-dose (95.0%) groups. Quantitative morphology, performed by light microscopy on a single ovary obtained from 16 of the 25 animals and read in a blinded fashion, revealed no differences in ovarian weight, capsular width and numbers, size, or proportion of healthy and atretic follicles among the three groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3213975     DOI: 10.1002/ar.1092220305

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  8 in total

Review 1.  Adrenal hyperandrogenism in the pathophysiology of polycystic ovary syndrome.

Authors:  E Carmina; R A Lobo
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 2.  Nonhuman primate models of polycystic ovary syndrome.

Authors:  David H Abbott; Lindsey E Nicol; Jon E Levine; Ning Xu; Mark O Goodarzi; Daniel A Dumesic
Journal:  Mol Cell Endocrinol       Date:  2013-01-29       Impact factor: 4.102

3.  Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys.

Authors:  David H Abbott; Alice F Tarantal; Daniel A Dumesic
Journal:  Am J Primatol       Date:  2009-09       Impact factor: 2.371

4.  Androgens stimulate early stages of follicular growth in the primate ovary.

Authors:  K A Vendola; J Zhou; O O Adesanya; S J Weil; C A Bondy
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

5.  Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats.

Authors:  Victoria Tyndall; Marie Broyde; Richard Sharpe; Michelle Welsh; Amanda J Drake; Alan S McNeilly
Journal:  Reproduction       Date:  2011-10-20       Impact factor: 3.906

6.  Inhibin removes the inhibitory effects of activin on steroid enzyme expression and androgen production by normal ovarian thecal cells.

Authors:  J M Young; A S McNeilly
Journal:  J Mol Endocrinol       Date:  2012-01-25       Impact factor: 5.098

Review 7.  Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review.

Authors:  Larissa Paixão; Ramon B Ramos; Anita Lavarda; Debora M Morsh; Poli Mara Spritzer
Journal:  Reprod Biol Endocrinol       Date:  2017-02-10       Impact factor: 5.211

Review 8.  Naturally Occurring and Experimentally Induced Rhesus Macaque Models for Polycystic Ovary Syndrome: Translational Gateways to Clinical Application.

Authors:  David H Abbott; Jeffrey Rogers; Daniel A Dumesic; Jon E Levine
Journal:  Med Sci (Basel)       Date:  2019-11-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.